RG
TXG icon

Retirement Group’s 10x Genomics TXG Stock Holding History

Retirement Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$38 Hold
1
– – ﹤0.01% 832
2023
Q4 		$56 Hold
1
– – ﹤0.01% 820
2023
Q3 		$41 Hold
1
– – ﹤0.01% 768
2023
Q2 		$56 Hold
1
– – ﹤0.01% 793
2023
Q1 		$0 Hold
1
– – ﹤0.01% 755
2022
Q4 		$0 Hold
1
– – ﹤0.01% 724
2022
Q3 		$0 Hold
1
– – ﹤0.01% 787
2022
Q2 		$0 Hold
1
– – ﹤0.01% 816
2022
Q1 		$0 Buy
+1
New +$87 ﹤0.01% 828

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Retirement Group's TXG Position: Q1 2024 in Review

Retirement Group held its 10x Genomics (TXG) position steady in Q1 2024 at 1 share worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #832.

Retirement Group first reported a position in TXG in Q1 2022 and has held it in 9 quarters since. The position peaked at $56 in Q4 2023. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Retirement Group held 1 share of 10x Genomics worth $38 as of Q1 2024.
  • Retirement Group left its 10x Genomics share count unchanged in Q1 2024.
  • 10x Genomics made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #832 holding.
  • Retirement Group first reported a position in 10x Genomics in Q1 2022 and has held it in 9 quarters since.
  • Retirement Group's 10x Genomics position peaked at $56 in Q4 2023.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.